Login
Home
Charts
Search
Watchlist
Products

Tejnaksh Healthcare Ltd

TEJNAKSH·BSE
13.35+0.45%Tue, 22 Sept '26 14:07

Tejnaksh Healthcare Ltd

TEJNAKSH
BSE
13.35
+0.45%
|Tue, 22 Sept '26 14:07
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
27Cr
Close
Close Price
13.35
Industry
Industry
Hospitals/Medical Services
PE
Price To Earnings
22.63
PS
Price To Sales
2.51
Revenue
Revenue
11Cr
Rev Gr TTM
Revenue Growth TTM
-12.97%
PAT Gr TTM
PAT Growth TTM
-33.15%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
333333333333
Growth YoY
Revenue Growth YoY%
-12.217.610.23.09.11.69.9-15.4-11.6-17.9-20.60.4
Expenses
ExpensesCr
222222322222
Operating Profit
Operating ProfitCr
111111111111
OPM
OPM%
36.634.131.234.334.435.421.822.726.226.327.825.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
111111100010
Tax
TaxCr
000000000000
PAT
PATCr
110111000000
Growth YoY
PAT Growth YoY%
-32.274.2275.06.63.7-8.7-65.0-49.2-48.2-16.723.8
NPM
NPM%
19.717.215.819.219.317.613.18.011.111.113.79.8
EPS
EPS
0.30.30.30.30.30.40.20.10.10.10.20.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
333333333333
Growth YoY
Revenue Growth YoY%
-12.217.610.23.09.11.69.9-15.4-11.6-17.9-20.60.4
Expenses
ExpensesCr
222222322222
Operating Profit
Operating ProfitCr
111111111111
OPM
OPM%
36.634.131.234.334.435.421.822.726.226.327.825.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
111111100010
Tax
TaxCr
000000000000
PAT
PATCr
110111000000
Growth YoY
PAT Growth YoY%
-32.274.2275.06.63.7-8.7-65.0-49.2-48.2-16.723.8
NPM
NPM%
19.717.215.819.219.317.613.18.011.111.113.79.8
EPS
EPS
0.30.30.30.30.30.40.20.10.10.10.20.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5714201712131212131111
Growth
Revenue Growth%
53.494.239.8-13.4-30.16.0-7.53.85.9-16.3-13.0
Expenses
ExpensesCr
24916138889988
Operating Profit
Operating ProfitCr
235444544433
OPM
OPM%
48.343.837.821.223.631.037.531.429.731.625.826.5
Other Income
Other IncomeCr
000200000000
Interest Expense
Interest ExpenseCr
001111011000
Depreciation
DepreciationCr
000111111111
PBT
PBTCr
234433432322
Tax
TaxCr
111111111101
PAT
PATCr
123322322211
Growth
PAT Growth%
44.466.8-1.4-31.6-3.635.9-36.3-1.526.4-47.1-33.1
NPM
NPM%
27.826.222.515.912.517.322.215.314.517.310.911.4
EPS
EPS
0.70.91.41.51.01.01.30.40.91.10.60.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5714201712131212131111
Growth
Revenue Growth%
53.494.239.8-13.4-30.16.0-7.53.85.9-16.3-13.0
Expenses
ExpensesCr
24916138889988
Operating Profit
Operating ProfitCr
235444544433
OPM
OPM%
48.343.837.821.223.631.037.531.429.731.625.826.5
Other Income
Other IncomeCr
000200000000
Interest Expense
Interest ExpenseCr
001111011000
Depreciation
DepreciationCr
000111111111
PBT
PBTCr
234433432322
Tax
TaxCr
111111111101
PAT
PATCr
123322322211
Growth
PAT Growth%
44.466.8-1.4-31.6-3.635.9-36.3-1.526.4-47.1-33.1
NPM
NPM%
27.826.222.515.912.517.322.215.314.517.310.911.4
EPS
EPS
0.70.91.41.51.01.01.30.40.91.10.60.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1221010101010101010
Reserves
ReservesCr
5683571012131617
Current Liabilities
Current LiabilitiesCr
01322222211
Non Current Liabilities
Non Current LiabilitiesCr
07667577632
Total Liabilities
Total LiabilitiesCr
716202225253031313030
Current Assets
Current AssetsCr
12357356665
Non Current Assets
Non Current AssetsCr
614171818212525252525
Total Assets
Total AssetsCr
716202225253031313030
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1221010101010101010
Reserves
ReservesCr
5683571012131617
Current Liabilities
Current LiabilitiesCr
01322222211
Non Current Liabilities
Non Current LiabilitiesCr
07667577632
Total Liabilities
Total LiabilitiesCr
716202225253031313030
Current Assets
Current AssetsCr
12357356665
Non Current Assets
Non Current AssetsCr
614171818212525252525
Total Assets
Total AssetsCr
716202225253031313030

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
42431192402
Investing Cash Flow
Investing Cash FlowCr
-3-8-3-2-12-11-1-140
Financing Cash Flow
Financing Cash FlowCr
06-1-20-32-1-2-4-1
Net Cash Flow
Net Cash FlowCr
011-10000100
Free Cash Flow
Free Cash FlowCr
3-832030130
CFO To PAT
CFO To PAT%
277.7118.1141.2100.354.157.1327.5118.5227.317.2145.8
CFO To EBITDA
CFO To EBITDA%
160.070.684.275.328.831.9193.757.6110.89.461.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
42431192402
Investing Cash Flow
Investing Cash FlowCr
-3-8-3-2-12-11-1-140
Financing Cash Flow
Financing Cash FlowCr
06-1-20-32-1-2-4-1
Net Cash Flow
Net Cash FlowCr
011-10000100
Free Cash Flow
Free Cash FlowCr
3-832030130
CFO To PAT
CFO To PAT%
277.7118.1141.2100.354.157.1327.5118.5227.317.2145.8
CFO To EBITDA
CFO To EBITDA%
160.070.684.275.328.831.9193.757.6110.89.461.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
980945637741717047432427
Price To Earnings
Price To Earnings
6.844.132.718.717.536.062.941.526.618.219.722.6
Price To Sales
Price To Sales
1.911.06.62.92.16.213.56.03.93.32.32.5
Price To Book
Price To Book
1.410.09.34.32.44.38.53.22.01.60.91.0
EV To EBITDA
EV To EBITDA
3.726.818.614.610.420.736.719.713.010.28.09.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
85.287.878.078.775.878.879.575.880.577.2
OPM
OPM%
48.343.837.821.223.631.037.531.429.731.625.826.5
NPM
NPM%
27.826.222.515.912.517.322.215.314.517.310.911.4
ROCE
ROCE%
34.021.030.126.917.114.716.111.310.913.46.56.5
ROE
ROE%
21.223.731.423.814.111.914.08.27.58.64.34.3
ROA
ROA%
19.312.316.114.18.68.49.55.75.67.43.93.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
980945637741717047432427
Price To Earnings
Price To Earnings
6.844.132.718.717.536.062.941.526.618.219.722.6
Price To Sales
Price To Sales
1.911.06.62.92.16.213.56.03.93.32.32.5
Price To Book
Price To Book
1.410.09.34.32.44.38.53.22.01.60.91.0
EV To EBITDA
EV To EBITDA
3.726.818.614.610.420.736.719.713.010.28.09.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
85.287.878.078.775.878.879.575.880.577.2
OPM
OPM%
48.343.837.821.223.631.037.531.429.731.625.826.5
NPM
NPM%
27.826.222.515.912.517.322.215.314.517.310.911.4
ROCE
ROCE%
34.021.030.126.917.114.716.111.310.913.46.56.5
ROE
ROE%
21.223.731.423.814.111.914.08.27.58.64.34.3
ROA
ROA%
19.312.316.114.18.68.49.55.75.67.43.93.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Tejnaksh Healthcare Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/5rzdq50jsq9re5997oq41ih1.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/rwg72zkiimcdk40xi0o2swug.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/jj9idmyedzjrf4gqbdn8gp3a.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/h2dgtojdoh4jwkzt824ri2cy.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ptz5pcrea1sgp9u7dnzzbt9v.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/fjzn9tczn00sax0orqf8pvit.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/ulf0a5tlxe5nxedmc6q7h1gx.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/2pg1gg72k72hdajsh6km7eu0.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/xj2712oz8jt5xsobqaa3kjd3.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ifbzm23id3tsufalmze54lwz.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/nnh88kh4pktfmr0n0frdty0d.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/gjh5x45rwrgkr4ikczxp6ugu.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/bp3slozbq1p0ghlnnj80eg7l.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/mct97b018rux6nuk9a4xii2u.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/mx4suatln77ox9erdkmn6wcl.pdf